Cite
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.
MLA
Jianlin Xu, et al. “Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.” Clinical Lung Cancer, vol. 17, no. 4, July 2016, pp. 309–14. EBSCOhost, https://doi.org/10.1016/j.cllc.2015.11.009.
APA
Jianlin Xu, Tianqing Chu, Bo Jin, Xue Dong, Yuqing Lou, Xueyan Zhang, Huiming Wang, Hua Zhong, Chunlei Shi, Aiding Gu, Liwen Xiong, Yizhuo Zhao, Liyan Jiang, Jie Zhang, Baohui Han, Xu, J., Chu, T., Jin, B., Dong, X., & Lou, Y. (2016). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer. Clinical Lung Cancer, 17(4), 309–314. https://doi.org/10.1016/j.cllc.2015.11.009
Chicago
Jianlin Xu, Tianqing Chu, Bo Jin, Xue Dong, Yuqing Lou, Xueyan Zhang, Huiming Wang, et al. 2016. “Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.” Clinical Lung Cancer 17 (4): 309–14. doi:10.1016/j.cllc.2015.11.009.